Literature DB >> 1833847

Thyroid carcinoma and hyperparathyroidism after radiation therapy for adolescent acne vulgaris.

S A De Jong1, J G Demeter, H Jarosz, A M Lawrence, E Paloyan.   

Abstract

Thyroid and parathyroid disease after head and neck irradiation in infancy and childhood is well known. Patients irradiated for facial acne were older and received a comparatively lower dose of radiation. These mitigating factors suggest a decreased incidence of thyroid and parathyroid disease in these patients. Over the past 28 years (1961 through 1989), 347 consecutive patients were operated on for radiation-associated thyroid and/or parathyroid disease. One hundred and ten patients in this group were irradiated for treatment for adolescent facial acne vulgaris. The interval between radiation exposure and thyroidectomy ranged from 7 to 57 years (mean, 30 years). The overall incidence of thyroid carcinoma was 31% (34 of 110 patients). Regional metastases in 10 patients (29%) were treated with modified radical neck dissection. Hyperparathyroidism, detected in 31% (34 of 110 patients) of this population, was treated with sub-total parathyroidectomy in all cases. The association of thyroid carcinoma and hyperparathyroidism after adolescent radiation exposure for acne vulgaris appears to be more than coincidental. The incidence of thyroid and parathyroid disease may be independent of the timing and dosage of radiation treatment. These thyroid and parathyroid tumors may develop decades after the initial radiation exposure.

Entities:  

Mesh:

Year:  1991        PMID: 1833847

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

Review 1.  Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Authors:  D G R Evans; J M Birch; R T Ramsden; S Sharif; M E Baser
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  Coexistence of primary hyperparathyroidism and thyroid disease.

Authors:  M Regal; C Páramo; R Luna Cano; L F Pérez Méndez; J M Sierra; I Rodríguez; R V García-Mayor
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

3.  Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications.

Authors:  T Pal; N Hamel; D Vesprini; K Sanders; M Mitchell; N Quercia; N Ng Cheong; A Murray; W Foulkes; S A Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

4.  Coexistence of parathyroid adenoma and papillary thyroid carcinoma.

Authors:  Yong Sang Lee; Kee-Hyun Nam; Woong Youn Chung; Hang-Seok Chang; Cheong Soo Park
Journal:  J Korean Surg Soc       Date:  2011-11-01

5.  HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.

Authors:  Alexia L Weeks; Scott G Wilson; Lynley Ward; Jack Goldblatt; Jennie Hui; John P Walsh
Journal:  BMC Med Genet       Date:  2016-08-17       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.